KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1314 |
|---|---|
| Product Name | Anti-Human CD140a Recombinant Antibody(Tovetumab) |
| Molecular Name | Tovetumab |
| Alias | Anti-CD140a Recombinant Antibody, Research Grade Tovetumab |
| CAS Number | 1243266-04-7 |
| Target | CD140a[Homo sapiens] |
| Isotype | IgG2 Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
| Buffer | PBS, pH7.5 |
| Background | Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer. It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer. Development was discontinued in 2013. This drug was developed by MedImmune, LLC. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
